PapersPMID:37683291
Astaxanthin prevents nephrotoxicity through Nrf2/HO-1 pathway.
- findings
- 2
- compound
- 1
- endpoints
- 2
- Study, every finding
- animal · not in humans · 10 days
- Dose studied, every finding
- 25, 50, or 75 mg/kg astaxanthin during the 10-day course, alongside MTX 10 mg/kg on days 6, 8, 10
- Population, every finding
- male Wistar rats with methotrexate-induced nephrotoxicity
What moved
How to read these marks →“Also, AST significantly reduced the amount of creatinine, urea, and uric acid in the serum and improved the activity of SOD and catalase in the kidney tissue (p < 0.05).”
- Decreases serum creatinine concentration
insufficient
- Decreases serum uric acid
insufficient
Study record
- Design
- animal study, in vivo
- Species
- animal
- Population
- male Wistar rats with methotrexate-induced (10 mg/kg on days 6, 8, 10) nephrotoxicity
- Participants
- not reported
- Comparator
- not stated in the paper
- Duration
- 10 days
- Endpoints measured
- 8
astaxanthin